An Impactful Year for Molecular Testing in GI Cancers

The guidelines released in 2017 are going to serve as the foundation for molecular testing for all gastrointestinal (GI) cancers, says Antonia R. Sepulveda, MD, PhD.

http://www.onclive.com/web-exclusives/an-impactful-year-for-molecular-testing-in-gi-cancers

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *